banner
LightNews
stemcellevidence.bsky.social
Stem Cell Evidence
@stemcellevidence.bsky.social
130 followers 490 following 130 posts
Curating the evidence in haematopoietic stem cell transplantation. Free monthly Stem Cell Evidence Alert http://bit.ly/2HMQtb5 @[email protected] #MedSky
bit.ly
Posts Media Videos Starter Packs
Pinned
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · 12d
The #StemCellEvidence monthly alert is out!
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
Image showing an extract of the Stem Cell Evidence Alert - September 2025
1 1
Reposted by Stem Cell Evidence
transfusionlib.bsky.social
Transfusion Evidence Library @transfusionlib.bsky.social · 1d
New from #Transfusion Evidence Library:

Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a #systematicreview and network meta-analysis
by Yang et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Image showing a PICO summary for: Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis by Yang et al. featured in the Transfusion Evidence Alert - September 2025
2 3
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · 1d
New from #StemCellEvidence:

Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA)
by Schoettler et al.
www.stemcellevidence.com/articles/408...
#MedSky
Image showing a PICO summary for: Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA) by Schoettler et al. featured in the Stem Cell Evidence Alert - September 2025
1 1
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · 2d
New from #StemCellEvidence:

Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell Transplants
by Saliba et al.
www.stemcellevidence.com/articles/407...
#MedSky
Image showing a PICO summary for: Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell Transplants by Saliba et al. featured in the Stem Cell Evidence Alert - September 2025
1 3
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · 3d
New from #StemCellEvidence:

Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (...)
by Robin et al.
www.stemcellevidence.com/articles/407...
#MedSky
Image showing a PICO summary for: Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trial by Robin et al. featured in the Stem Cell Evidence Alert - September 2025
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · 5d
From the #StemCellEvidence Alert:

Neurological manifestations of chronic graft versus host disease
by Koren et al.
www.stemcellevidence.com/articles/408...
#MedSky
Image showing a PICO summary for: Neurological manifestations of chronic graft versus host disease by Koren et al. featured in the Stem Cell Evidence Alert - September 2025
2 1
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · 5d
New from #StemCellEvidence:

Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
by Hernández-Boluda et al.
www.stemcellevidence.com/articles/408...
#MedSky
Image showing a PICO summary for: Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT by Hernández-Boluda et al. featured in the Stem Cell Evidence Alert - September 2025
1
Reposted by Stem Cell Evidence
transfusionlib.bsky.social
Transfusion Evidence Library @transfusionlib.bsky.social · 5d
New from #Transfusion Evidence Library:

Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes
by Karakas et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Image showing a PICO summary for: Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes by Karakas et al. featured in the Transfusion Evidence Alert - September 2025
1 1
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · 8d
From the #StemCellEvidence Alert:

Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood (...)
by Capes et al.
www.stemcellevidence.com/articles/407...
#MedSky
Image showing a PICO summary for: Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplantation cyclophosphamide alone: A retrospective study on behalf of the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation by Capes et al. featured in the Stem Cell Evidence Alert - September 2025
1
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · 10d
From the #StemCellEvidence Alert:

Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers
by Caballero-Velázquez et al.
www.stemcellevidence.com/articles/407...
#MedSky
Image showing a PICO summary for: Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers by Caballero-Velázquez et al. featured in the Stem Cell Evidence Alert - September 2025
2 1
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · 10d
New from #StemCellEvidence:

Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party
by Berning et al.
www.stemcellevidence.com/articles/408...
#MedSky
Image showing a PICO summary for: Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party by Berning et al. featured in the Stem Cell Evidence Alert - September 2025
1
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · 11d
From the #StemCellEvidence Alert:

Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial
by Stelljes et al.
www.stemcellevidence.com/articles/407...
#MedSky
Image showing a PICO summary for: Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial by Stelljes et al. featured in the Stem Cell Evidence Alert - September 2025
2 1
Reposted by Stem Cell Evidence
transfusionlib.bsky.social
Transfusion Evidence Library @transfusionlib.bsky.social · 11d
From the #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025

#Tranexamicacid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (...)
by the TREATT Trial Investigators
www.transfusionevidencelibrary.com/articles/396...
#MedSky
Image showing a PICO summary for: #Tranexamicacid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial by the TREATT Trial Investigators featured in the Transfusion Evidence Round-Up: Blood Cancer Awareness Month 2025
1 1
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · 12d
The #StemCellEvidence monthly alert is out!
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
Image showing an extract of the Stem Cell Evidence Alert - September 2025
1 1
Reposted by Stem Cell Evidence
transfusionlib.bsky.social
Transfusion Evidence Library @transfusionlib.bsky.social · 16d
New from the #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025

Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: An Overview of Systematic Reviews
by He et al.
www.stemcellevidence.com/articles/362...
#MedSky @isbt.bsky.social @stemcellevidence.bsky.social
Image showing a PICO summary for: Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: An Overview of Systematic Reviews by He et al. featured in the Transfusion Evidence Round-Up: Blood Cancer Awareness Month 2025
1 1
Reposted by Stem Cell Evidence
transfusionlib.bsky.social
Transfusion Evidence Library @transfusionlib.bsky.social · 18d
New from the #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025

The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A #SystematicReview and #MetaAnalysis
by Chen et al.
www.stemcellevidence.com/articles/387...
#MedSky
Image showing a PICO summary for: The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A #SystematicReview and #MetaAnalysis by Chen et al. featured in the Transfusion Evidence Round-Up: Blood Cancer Awareness Month 2025
2 2
Reposted by Stem Cell Evidence
transfusionlib.bsky.social
Transfusion Evidence Library @transfusionlib.bsky.social · 17d
From the #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025

Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa (...)
by Garcia-Manero et al.
www.transfusionevidencelibrary.com/articles/403...
#MedSky
Image showing a PICO summary for: Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial by Garcia-Manero et al. featured in the Transfusion Evidence Round-UP: Blood Cancer Awareness Month 2025
2 3
Reposted by Stem Cell Evidence
isbt.bsky.social
International Society of Blood Transfusion @isbt.bsky.social · 23d
New Talking Transfusion episode!

For Blood Cancer Awareness month the hosts chat with reviewers from the Transfusion Evidence Roundup, exploring the latest findings, clinical challenges and highlight the importance of transfusion.

Listen here: open.spotify.com/episode/63YC...

#TalkingTransfusion
Episode 4: Blood Cancer Awareness Month
open.spotify.com
3 3
Reposted by Stem Cell Evidence
transfusionlib.bsky.social
Transfusion Evidence Library @transfusionlib.bsky.social · 24d
The #Transfusion Evidence Round-Up: #BloodCancerAwarenessMonth 2025 is out!

See the top articles and subscribe here:
www.transfusionevidencelibrary.com/alerts/latest

@isbt.bsky.social @stemcellevidence.bsky.social
Image showing an extract of the Transfusion Evidence Round-Up: Blood Cancer Awareness Month - 2025
1 1
Reposted by Stem Cell Evidence
transfusionlib.bsky.social
Transfusion Evidence Library @transfusionlib.bsky.social · 29d
New from #Transfusion Evidence Library:

Comparative efficacy and safety of rhTPO, romiplostim, and eltrombopag in the treatment of pediatric primary immune thrombocytopenia: a systematic review and network meta-analysis
by Zhang et al.

www.transfusionevidencelibrary.com/alerts/artic...

#MedSky
Image showing a PICO summary for: Comparative efficacy and safety of rhTPO, romiplostim, and eltrombopag in the treatment of pediatric primary immune thrombocytopenia: a systematic review and network meta-analysis by Zhang et al. Featured in the Transfusion Evidence Alert – August 2025
2 2
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · 29d
From the #StemCellEvidence Alert:

Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study
by Zeiser et al.

www.stemcellevidence.com/articles/405...

#MedSky
Image showing a PICO summary for: Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study by Zeiser et al. Featured in Stem Cell Evidence Alert – August 2025
3 2
Reposted by Stem Cell Evidence
transfusionlib.bsky.social
Transfusion Evidence Library @transfusionlib.bsky.social · Sep 11
From the #Transfusion Evidence Alert:

Effectiveness of Prophylactic Tranexamic Acid in Reducing Blood Loss in Children Undergoing Open Nephrectomy for Wilms Tumor: A Randomized Controlled Study
by Verma et al.

www.transfusionevidencelibrary.com/alerts/artic...

#MedSky
Image showing a PICO summary for: Effectiveness of Prophylactic Tranexamic Acid in Reducing Blood Loss in Children Undergoing Open Nephrectomy for Wilms Tumor: A Randomized Controlled Study by Verma et al. Featured in the Transfusion Evidence Alert – August 2025
2 2
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · Sep 11
New from #StemCellEvidence:

Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis
by Perales et al.

www.stemcellevidence.com/articles/406...

#MedSky
Image showing a PICO summary for: Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis by Perales et al. Featured in Stem Cell Evidence Alert – August 2025
3 2
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · Sep 10
From the #StemCellEvidence Alert:

Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center
By Oran et al.

www.stemcellevidence.com/articles/407...
#MedSky
2 1
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · Sep 9
New from #StemCellEvidence:

Phase I/II clinical trial on the safety and preliminary efficacy of donor-derived anti-leukemia cytotoxic T lymphocytes for the prevention of leukemia relapse (...)
by Montagna et al.
www.stemcellevidence.com/articles/405...
#MedSky
Image showing a PICO summary for: Phase I/II clinical trial on the safety and preliminary efficacy of donor-derived anti-leukemia cytotoxic T lymphocytes for the prevention of leukemia relapse in children given haploidentical hematopoietic stem cell transplantation: study rational and design by Montagna et al. featured in the Stem Cell Evidence Alert - August 2025
1 2 2
stemcellevidence.bsky.social
Stem Cell Evidence @stemcellevidence.bsky.social · Sep 8
From the #StemCellEvidence Alert:

Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia
by Levis et al.

www.stemcellevidence.com/articles/405...

#MedSky
1 2